BTG Pactual Global Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

BTG Pactual Global Asset Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-177,524	Closed	-$30.7M	–	267
2015 Q1	$30.7M	Buy	+177,524	New	+$26.1M	2.36%	11
2014 Q2	–	Sell	-3,890	Closed	-$403K	–	289
2014 Q1	$403K	Buy	+3,890	New	+$398K	0.09%	123

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

BTG Pactual Global Asset Management's SLXP Position: Q2 2015 in Review

BTG Pactual Global Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 177,524 shares — an estimated $30.7M sold.

BTG Pactual Global Asset Management first reported a position in SLXP in Q1 2014 and held it in 2 quarters. The position peaked at $30.7M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

BTG Pactual Global Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
BTG Pactual Global Asset Management sold 177,524 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $30.7M.
BTG Pactual Global Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q1 2014 and held it in 2 quarters.
BTG Pactual Global Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $30.7M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on BTG Pactual Global Asset Management's 13F filing for Q2 2015, filed 12 Aug 2015.